How LabGenius uses AI and protein engineering to design new therapeutics

How LabGenius combines synthetic biology, computational biology (and data science!) We are excited to be co-hosting LabGenius with Imperial College Synthetic Biology Society for our second event of the Autumn term. Harry Rickerby will be discussing the company's latest work in protein engineering and drug discovery, with a Q&A section at the end. We look forward to seeing you there! Abstract: LabGenius is a startup that lives at the interface between synthetic biology, computational biology and data science. In this talk, I will give you an insight into the problems we are solving in protein engineering and drug discovery, and how we’re going about solving them.